GL1X · GenesisL1 explorer

MolNFT v1 · #119505 · protein

Crystal structure of human JMJD2A in complex with D-threo-isocitrate

5FY8 · Lysine-specific demethylase 4A: “Crystal structure of human JMJD2A in complex with D-threo-isocitrate”. X-ray diffraction, 3 ligands (N81, NI, ZN), 7 pockets (best druggability 0.72). MolNFT v1 #119505 on GenesisL1: 3D structure…

PDB
5FY8
Type
protein
Length
697 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Lysine-specific demethylase 4A
EC
1.14.11.-
UniProt
O75164
Ligands
N81, NI, ZN
Pockets
7 · best druggability 0.72

Structure

x-ray diffraction · 2 distinct chains · 30% helix, 24% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ALysine-specific demethylase 4A (EC 1.14.11.-)protein35031% helix, 24% strandO75164
BLysine-specific demethylase 4A (EC 1.14.11.-)protein34730% helix, 24% strandO75164

Ligands and binding sites

  • N81 · 3-carboxy-2,3-dideoxy-D-erythro-pentaric acid · ligand · 2 copies · chains A, B
  • NI · Nickel (II) ion · metal · 2 copies · chains A, B
  • ZN · Zinc ion · metal · 2 copies · chains A, B
  • EDO · 1,2-ethanediol · additive · 7 copies · chains A, B
  • DMS · Dimethyl sulfoxide · additive · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

7 pockets found on a 1 Å grid, 4 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13590.720.8338NI, N81
23710.710.8339NI, N81
37140.700.7774EDO
41190.500.8027EDO
52200.470.7433empty

Interfaces

1 interface between chains.

  • A–B · 408 Ų buried · 5 hydrogen bonds · protein-protein

Compared structures

  • 5FY8 · Crystal structure of human JMJD2A in complex with D-threo-isocitrate · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.